Nykode Therapeutics ASA — Director's Dealing 2024

Mar 4, 2024

1	Details of the person discharging managerial responsibilities
a)	Name	Harald Gurvin
b)	Position	Chief Financial Officer
2	Reason for notification
a)	Initial notification/ Amendment	Initial
3	Details of issuer
a)	Name	Nykode Therapeutics ASA
b)	LEI	254900UKQHWYZJD22017
4	conducted	Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been
a)	Description of the financial instrument, type of instrument	Shares in Nykode Therapeutics ASA (ISIN: NO0010714785)
b)	Nature of the transaction	Acquisition of shares
c)	Price(s) and volume(s)	Price(s)	Volume(s)
		NOK 16.55	1,250
		NOK 16.57	3,045
		NOK 16.58	311
		NOK 16.59	2,107
		NOK 16.60	12,028
		NOK 16.61	1,250
		NOK 16.63	9
d)	Aggregated information	Price	NOK 16.59158
	-Average price,	Volume	20,000
	aggregated volume and total amount	Total amount	NOK 331,831.63
e)	Date of the transaction	04.03.2024
f)	Place of the transaction	XOSL - Oslo Stock Exchange